Notable Ultragenyx Pharmaceutical Insider Trades $1.14 Million In Company Stock
Karah Parschauer, EVP And General Counsel at Ultragenyx Pharmaceutical (NASDAQ:RARE), made a large buy and sell of company shares on September 8, according to a new SEC filing.